Mikael Aagaard

Papers

Total Citations

H-Index

About

Mikael Aagaard is a leading researcher in urological oncology, with a primary focus on the surgical management of testicular cancer. His work centers on optimizing treatment outcomes for patients with non-seminomatous germ cell tumors, particularly those requiring post-chemotherapy retroperitoneal lymph node dissection (RPLND). Aagaard’s major contribution includes a comprehensive systematic review that critically evaluates the oncological outcomes and complications of this complex surgery, providing essential evidence for balancing recurrence risk with surgical morbidity. This highly cited study, with 14 citations, has become a key reference for clinicians navigating the challenges of residual retroperitoneal masses. Beyond this, Aagaard’s research advances the understanding of bilateral RPLND techniques, aiming to refine surgical approaches to reduce complications while maintaining excellent cancer control. His work is instrumental in shaping modern guidelines for testicular cancer care, offering clear, data-driven insights that directly impact patient survival and quality of life. For students and researchers, Aagaard exemplifies how rigorous evidence synthesis can bridge the gap between surgical innovation and clinical practice.